# DEVELOPMENT STATE — SBGlobal Plus
**Updated:** 2026-09-21 · **Checkpoint:** `DEV-COMMERCIAL-APPLY-EVIDENCE-GATE-001`

Development is **IN PROGRESS — COMMERCIAL ATOMIC APPLY / PUBLICATION PREREQUISITES**.

Verified feature executable `1704259d61c77937eaf866162ca67689dee3b714` / `c5656d68ddc50b480fec63117d267e8a0def1bd2`:
- **265/265 Core PASS**
- **61/61 PostgreSQL PASS**
- **46 migrations / 40 verification files bootstrap PASS**
- **Next.js 15.5.25 production build PASS**
- **Database Verify PASS**
- **389 blobs / 151 Markdown / 81 source / 57 tests in feature tree**

DD-077 now consumes persisted DD-066 evidence through the existing least-privilege Commercial compiler role. It requires the current/latest assessment, exact live Subscription/source/route binding, correct producer-owned latest route evidence, resolved remediation provenance and reached NEXT_RENEWAL effective time.

This is deliberately a read-only authorization gate. It is **not yet atomic with DD-065 publication**, so it is not sufficient by itself to expose public changePlan.

Still unfinished: concrete DD-076 evaluator semantics/producer, DD-066 write orchestration, Billing/Workflow producer runtimes, final snapshot fact/source metadata materialization where still unbound, same-transaction evidence validation + DD-065 mutation, and public changePlan.

Next independent governed dependency: source-audit the **DD-077 evidence checks → DD-065 publication transaction atomic binding** and implement only evidence-backed checks inside the existing dedicated compiler transaction.

RawSourceCorpus immutable; `main` unmerged; PR #2 draft/review-only.
